Differential regulation of the insulin-like growth factor II mRNA-binding protein genes by architectural transcription factor HMGA2 - PubMed (original) (raw)

Differential regulation of the insulin-like growth factor II mRNA-binding protein genes by architectural transcription factor HMGA2

Jan R Brants et al. FEBS Lett. 2004.

Free article

Abstract

The developmentally regulated architectural transcription factor, high mobility group A2 (HMGA2), is involved in growth regulation and plays an important role in embryogenesis and tumorigenesis. Little is known, however, about its downstream targets. We performed a search for genes of which expression is strongly altered during embryonic development in two HMGA2-deficient mouse strains, which display a pygmy-phenotype, as compared to wild-type mice. We found that the insulin-like growth factor II mRNA-binding protein 2 gene (IMP2), but not its family members IMP1 and IMP3, was robustly downregulated in mutant E12.5 embryos. Furthermore, we show that wild-type HMGA2 and its tumor-specific truncated form have opposite effects on IMP2 expression. Our results clearly indicate that HMGA2 differentially regulates expression of IMP family members during embryogenesis.

PubMed Disclaimer

Cited by

Endocrine Disrupting Chemicals in Polycystic Ovary Syndrome: The Relevant Role of the Theca and Granulosa Cells in the Pathogenesis of the Ovarian Dysfunction.
Jozkowiak M, Piotrowska-Kempisty H, Kobylarek D, Gorska N, Mozdziak P, Kempisty B, Rachon D, Spaczynski RZ. Jozkowiak M, et al. Cells. 2022 Dec 31;12(1):174. doi: 10.3390/cells12010174. Cells. 2022. PMID: 36611967 Free PMC article. Review.
HMGA2 drives the IGFBP1/AKT pathway to counteract the increase in P27KIP1 protein levels in mtDNA/RNA-less cancer cells.
Maruyama T, Saito K, Higurashi M, Ishikawa F, Kohno Y, Mori K, Shibanuma M. Maruyama T, et al. Cancer Sci. 2023 Jan;114(1):152-163. doi: 10.1111/cas.15582. Epub 2022 Sep 26. Cancer Sci. 2023. PMID: 36102493 Free PMC article.
The analysis of N6-methyladenosine regulators impacting the immune infiltration in clear cell renal cell carcinoma.
Li J, Cao J, Liang C, Deng R, Li P, Tian J. Li J, et al. Med Oncol. 2022 Jan 29;39(4):41. doi: 10.1007/s12032-021-01645-0. Med Oncol. 2022. PMID: 35092501
Comparative proteomic analysis of nuclear and cytoplasmic compartments in human cardiac progenitor cells.
Albericio G, Aguilar S, Torán JL, Yañez R, López JA, Vázquez J, Mora C, Bernad A. Albericio G, et al. Sci Rep. 2022 Jan 7;12(1):146. doi: 10.1038/s41598-021-03956-8. Sci Rep. 2022. PMID: 34997006 Free PMC article.
Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma.
Carrabotta M, Laginestra MA, Durante G, Mancarella C, Landuzzi L, Parra A, Ruzzi F, Toracchio L, De Feo A, Giusti V, Pasello M, Righi A, Lollini PL, Palmerini E, Donati DM, Manara MC, Scotlandi K. Carrabotta M, et al. Cancer Res. 2022 Feb 15;82(4):708-720. doi: 10.1158/0008-5472.CAN-21-1222. Cancer Res. 2022. PMID: 34903601 Free PMC article.

Differential regulation of the insulin-like growth factor II mRNA-binding protein genes by architectural transcription factor HMGA2 - PubMed (original) (raw)